Hilar Fat Infiltration: An Independent Prognostic Factor in Metastatic Clear Cell Renal Cell Carcinoma with Sunitinib First-Line Treatment

被引：0
|
作者：
Kammerer-Jacquet, Solene-Florence
Brunot, Angelique
Benasalah, Karim
Campillo-Gimenez, Boris
Lefort, Mathilde
Bayat, Sahar
Ravaud, Alain
Dupuis, Frantz
Yacoub, Mokrane
Verhoest, Gregory
Mathieu, Romain
Peyronnet, Benoit
Lespagnol, Alexandra
Mosser, Jean
Edeline, Julien
Laguerre, Brigitte
Bernhard, Jean-Christophe
Rioux-Leclercq, Nathalie
机构：
[1] Univ Hosp, Rennes, France
[2] Ctr Eugene Marquis, Rennes, France
[3] EHESP, Rennes, France
[4] Univ Hosp, Bordeaux, France
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
947
引用
收藏
页码：234A / 234A
页数：1
相关论文
共 50 条
  • [41] Efficacy, safety, and prognostic indicators of first-line sunitinib in patients with metastatic renal cell carcinoma: A single center experience
    Abd Ghafar, Nahjatul Kursyiah
    Alip, Adlinda
    Ong, Teng Aik
    Yap, Ning Yi
    Saad, Marniza
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (06) : 1303 - 1311
  • [42] First-line treatment of metastatic clear cell renal cell carcinoma: a decision-making analysis among experts
    Aeppli, S.
    Schmaus, M.
    Eisen, T.
    Escudier, B.
    Gruenwald, V
    Larkin, J.
    McDermott, D.
    Oldenburg, J.
    Porta, C.
    Rini, B., I
    Schmidinger, M.
    Sternberg, C. N.
    Rothermundt, C.
    Putora, P. M.
    [J]. ESMO OPEN, 2021, 6 (01)
  • [43] Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma-Analysis Using Diagnostic Nodes
    Rothermundt, Christian
    Bailey, Alexandra
    Cerbone, Linda
    Eisen, Tim
    Escudier, Bernard
    Gillessen, Silke
    Gruenwald, Viktor
    Larkin, James
    McDermott, David
    Oldenburg, Jan
    Porta, Camillo
    Rini, Brian
    Schmidinger, Manuela
    Sternberg, Cora
    Putora, Paul M.
    [J]. ONCOLOGIST, 2015, 20 (09): : 1028 - 1035
  • [44] Bevacizumab - In first-line treatment of advanced and/or metastatic renal cell carcinoma
    Frampton, James E.
    Keating, Gillian M.
    [J]. BIODRUGS, 2008, 22 (02) : 113 - 120
  • [45] BevacizumabIn First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma
    James E. Frampton
    Gillian M. Keating
    [J]. BioDrugs, 2008, 22 : 113 - 120
  • [46] Risk of treatment failure after first-line sunitinib therapy in patients with metastatic renal cell carcinoma.
    Chen, Chi-Chang
    Hess, Gregory P.
    Liu, Zhimei
    Gesme, Dean H.
    Agarwala, Sanjiv S.
    Hill, Jerrold W.
    Guo, Min Amy
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [47] Pretreatment Lymphocyte to Monocyte Ratio is an Independent Prognostic Factor in Metastatic Clear Cell Renal Cell Carcinoma
    Gu, Liangyou
    Ma, Xin
    Xie, Yongpeng
    Li, Hongzhao
    Wang, Lei
    Chen, Luyao
    Zhao, Wenlei
    Zhang, Yu
    Zhang, Xu
    [J]. CLINICAL GENITOURINARY CANCER, 2017, 15 (03) : E369 - E377
  • [48] The efficacy of axitinib as a first-line treatment for metastatic renal cell carcinoma
    Kameda, Tomohiro
    Takayama, Tatsuya
    Sugihara, Toru
    Takeshima, Saki
    Yamazaki, Masahiro
    Komatsubara, Maiko
    Kamei, Jun
    Fujisaki, Akira
    Ando, Satoshi
    Kurokawa, Shinsuke
    Fujimura, Tetsuya
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (04) : 241 - 246
  • [49] Phase I study of dalteparin in combination with sunitinib as first-line treatment in patients with metastatic renal cell carcinoma
    Pill, Roberto
    Pal, Sumanta Kumar
    George, Saby
    Voortman, Jens
    Danchalvijitr, Pongwut
    Adelalye, Remi
    Webb, Nancy
    Poslinski, Diane
    Groman, Adrienne
    Hutson, Alan
    Verheul, Honk M. W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [50] Comparative efficacy of sunitinib versus sorafenib as the first-line treatment for patients with metastatic renal cell carcinoma.
    Park, Seongjoon
    Lee, Jae-Lyun
    Park, Inkeun
    Park, Kwonoh
    Ahn, Yongchel
    Ahn, Jin-Hee
    Lee, Dae Ho
    Song, Cheryn
    Hong, Jun Hyuk
    Kim, Choung-Soo
    Ahn, Hanjong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345